CUH2A Europe, Inc. Company Profile

07:07 EDT 23rd March 2018 | BioPortfolio

CUH2A is a recognized leader in the planning and design of technologically complex facilities for science and technology organizations. We have dedicated our practice to serving pharmaceutical, government, institutional research, academic, corporate and emerging technology clients with their research facility requirements for 40 years.The name “CUH2A” is an acronym derived from the first initials of the last name of the original five partners: Philip S. Collins, Harrison J. Uhl, Jr., Richard W. Hoisington, Kurt M. Anderson, and Ahmed A. Azmy. Collins founded the firm in 1962 when he won the design competition for the 1964 New York World’s Fair New Jersey Pavilion. Uhl and Hoisington joined him to assist with the pavilion’s contract documents and field inspection. Anderson joined the firm in 1965. The firm adopted its present name in 1976 when Azmy joined, completing the “2A”.
Since 1962, CUH2A has grown in size from three founding partners to several hundred design professionals; our guiding principles have remained the same.


21 Wootton Street
United Kingdom



News Articles [4 Associated News Articles listed on BioPortfolio]

Cancer Core Europe

Fabien Calvo talks to ecancer at EAPM 2017 in Belfast. He spoke about how precision medicine can improve the quality of health in Europe.  He outlines Cancer Core Europe which is a coalition of sev...

Five Themes For BIO-Europe 2017

From BIO-Europe, the biggest pharma and biotech partnering meeting in Europe, Scrip lists the five hottest topics of discussion and...   

Interviewing Europe’s Most Intense Investor about Trends in Biotech

I interviewed Kate Bingham of SV Health Investors about Alzheimer’s, checkpoint inhibitors, gender diversity and more at BIO Europe. BIO Europe 2017 was off to a racing start on Monday morning w...

Spring Into Action at Refresh Amsterdam & BIO-Europe Spring

BIO-Europe Spring is on its way and Refresh is coming with it. Amsterdam is our next Refreshing stop! We’re inviting you to join us at BIO-Europe Spring where we are co-hosting Refresh on the 14...

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Nizatidine [Dispensing Solutions Inc.]

Nizatidine Capsules USP Rx only


Akne-mycin (Erythromycin)

Manicure by opi - finishing butter [OPI Products, Inc]


Retavase [EKR Therapeutics, Inc.]

Retavase Reteplase, recombinant

PubMed Articles [337 Associated PubMed Articles listed on BioPortfolio]

The genomic history of southeastern Europe.

Farming was first introduced to Europe in the mid-seventh millennium bc, and was associated with migrants from Anatolia who settled in the southeast before spreading throughout Europe. Here, to unders...

Current Practice of Airway Stenting in the Adult Population in Europe: A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP).

Airway stenting (AS) commenced in Europe circa 1987 with the first placement of a dedicated silicone airway stent. Subsequently, over the last 3 decades, AS was spread throughout Europe, using differe...

Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE.

Are there any changes in the treatments involving ART and IUI initiated in Europe during 2013 compared with previous years?

The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic.

1 million people are predicted to get infected with Lyme disease in the USA in 2018. Given the same incidence rate of Lyme disease in Europe as in the USA, then 2.4 million people will get infected wi...

Expansion of the 'Antibiotic Guardian' one health behavioural campaign across Europe to tackle antibiotic resistance: pilot phase and analysis of AMR knowledge.

Antimicrobial resistance (AMR) is a major public health threat. The UK Antibiotic Guardian (AG) behavioural change campaign developed to tackle AMR was expanded across Europe through translation into ...

Clinical Trials [542 Associated Clinical Trials listed on BioPortfolio]

In-market Utilisation of Liraglutide Used for Weight Management in Europe: a Retrospective Medical Record Review Study

This study is conducted in Europe. The aim of this study is to investigate usage of liraglutide for weight management in clinical practice.

RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)

This multicenter, prospective, single-arm, phase 3 study will assess the proportion of disease-free patients, starting from administration of the first study treatment to at least 12-month...

EUROpE-RSI (EURopean Online Evaluation RSI Study)

The investigators want to identify and show differences in standards and procedures of in-hospital rapid sequence induction by collecting data with an online survey for anaesthetist in Eur...

A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe

This is a prospective, non-interventional study (NIS) measuring health-related quality of life (HRQoL), treatment satisfaction, and other patient-reported outcomes (PROs) of ADPKD patients...

The Metabolic Road to Diastolic Heart Failure: Diastolic Heart Failure Study

The main objective is to replicate the validation of omics biomarkers of left ventricular diastolic dysfunction in patients with metabolic syndrome. The aim was to recruit overall 750 pa...

Companies [828 Associated Companies listed on BioPortfolio]

CUH2A Europe Inc (UK)

CUH2A is a recognized leader in the planning and design of technologically complex facilities for science and technology organizations. We have dedicated our practice to serving the needs of instituti...

CUH2A Europe, Inc.

CUH2A is a recognized leader in the planning and design of technologically complex facilities for science and technology organizations. We have dedicated our practice to serving pharmaceutical, govern...

Europe Unlimited

Europe Unlimited profiles and connects the community of Europe’s best tech entrepreneurs and international capital through research, networking events and consulting. As such, we are in a position t...

HealthLink Europe

“We are the gateway to Europe for U.S.-based medical technology companies.” Rick Hughes, President, HealthLink Europe


TESCOM EUROPE offers customized solutions and services for all pressure and flow control applications. We design, engineer, manufacture and install components and automated systems for pressure and fl...

More Information about "CUH2A Europe, Inc." on BioPortfolio

We have published hundreds of CUH2A Europe, Inc. news stories on BioPortfolio along with dozens of CUH2A Europe, Inc. Clinical Trials and PubMed Articles about CUH2A Europe, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CUH2A Europe, Inc. Companies in our database. You can also find out about relevant CUH2A Europe, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record